Our results prove that anti-gliadin antibodies might be present well before the appearance of anti-TG2 antibodies in the serum, but at this stage do not have a diagnostic significance and are not indicative of CeD, and therefore should not be used as diagnostic tool. This evidence concerns the gene TGM2 and cranioectodermal dysplasia.